Accentia Biopharmaceuticals, Inc.
| OTC Markets: ABPI
Accentia Biopharmaceuticals, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative therapies that address the unmet medical needs of patients by utilizing therapeutic clinical products, including personalized immunotherapies designed to treat autoimmune related diseases and cancer. Through its Biovest International, Inc. subsidiary, the company is developing and commercializing the AutovaxID and other novel hollow fiber perfusion bioreactor systems, as instruments for the production of a broad range of cell culture products, including patient-specific medicines such as BiovaxID. Accentia Biopharmaceuticals was founded in March 2002 and is headquartered in Tampa, FL.